We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Indian drugmaker Ranbaxy Laboratories announced that the Federal Court of Australia has handed down a favorable decision in the company's case against Pfizer regarding Pfizer's Australian atorvastatin patent 628198.
Common OTC pain relievers would have to carry prominent new warnings about the potential for stomach bleeding and liver damage under an FDA-proposed rule.
AstraZeneca announced yesterday that the European Patent Office (EPO) has ruled that one of the company's European substance patents for Nexium (0652872) will be rejected, following an appeal from the German generic manufacturer Ratiopharm.
Bharat Biotech International has launched a new rabies vaccine, Rabirix, in India that can be used both for preventing rabies and for treatment in case of infection due to animal bite or contact with saliva of an infected animal.
Israeli drugmaker Teva Pharmaceutical Industries announced it has begun commercially shipping bupropion hydrochloride extended-release tablets 300 mg, the generic version of Biovail's antidepressant Wellbutrin XL, pursuant to an agreement with Impax Laboratories and Anchen Pharmaceuticals.
Moving to cut in on the proposed merger between CVS and Caremark Rx, Express Scripts is proposing to acquire all of the remaining shares of Caremark for about $26 billion, the company announced.
GlaxoSmithKline (GSK) and Danish drugmaker Genmab have announced
a worldwide agreement to co-develop and commercialize Genmab's HuMax-CD20 (ofatumumab), a fully human monoclonal antibody in development for treating CD20-positive B-cell chronic lymphocytic leukemia, follicular non-Hodgkin's lymphoma and rheumatoid arthritis.
Indian drugmaker Unichem Laboratories, after acquiring the remaining 40 percent of the Irish firm Niche Generics, is planning to set up an additional formulation and packaging facility in Ireland.
Activists have warned that Kenya risks falling victim to new drug-resistant strains of tuberculosis (TB), found elsewhere in Africa, if the government fails to take the TB epidemic more seriously, reports UN Integrated Regional Information Networks (IRIN).